Erythroid properties of K562 cells
Jean‐Luc Villeval(Inserm), Ugo Testa(Istituto Superiore di Sanità), Matthias Titeux(Inserm), M. Garbaz(Inserm), Pier Giuseppe Pelicci(Office of Technology Transfer), Paul A. Edwards(University of Cambridge), F. Houesche(Inserm), P Thomopoulos(Inserm), Antonio Tabilio(University of Perugia), H Rochant(Inserm), J Breton-Gorius(Inserm), William Vainchenker(Inserm), A Henri(Inserm)
Cited by 61
Related Papers
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
|Nature reviews. Cancer|2006|2.2k
A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency
|New England Journal of Medicine|2003|1.8k
A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction
|Cell|1992|1.3k
TLR3 Deficiency in Patients with Herpes Simplex Encephalitis
|Science|2007|1.1k